ADITXT INC (ADTX) Stock News
NASDAQ:ADTX - Nasdaq - US0070257037 - Common Stock - Currency: USD
ADTX Latest News, Press Releases and Analysis
Unusual volume stocks in Friday's session
Discover the stocks with unexpected trading volume in today's session on the US markets.
Which stocks are most active on Thursday?
Discover the most active stocks in Thursday's session. Stay informed about the stocks that are generating the most trading volume!
What's going on in today's pre-market session
Stay updated with the stocks that are on the move in Thursday's pre-market session.
Discover the most active stocks in Wednesday's session. Stay informed about the stocks that are generating the most trading volume!
Curious about the most active stocks on Wednesday? Find out which stocks are dominating the market action!
Evofem Biosciences Announces Financial Results for the Third Quarter of 2024
/PRNewswire/ -- Women's health innovator Evofem Biosciences, Inc. ("Evofem" or "the Company") (OTCQB: EVFM) today announced financial results for the third...
Aditxt Provides Update on Equity Line of Credit, ATM Usage, and Outstanding Number of Shares
Aditxt’s Target Acquisition Appili Therapeutics Announces Results of Special Meeting of Shareholders
Sylvia Hermina Joins Aditxt’s Board of Directors, Elevating Leadership with Broader Perspectives
Aditxt Completes Third Parent Equity Investment Under Amended and Restated Merger Agreement With Evofem
Aditxt Delivers Shareholder Update and 2024 Year-End Plan
Evofem Biosciences Files Preliminary Proxy for Stockholder Approval of the Acquisition by Aditxt
InvestorNewsBreaks – Aditxt (NASDAQ: ADTX) Subsidiary Signs Agreement with Evofem Biosciences Inc. (OTCQB: EVFM) Involving Unique Endometriosis Diagnostic Test
Aditxt (NASDAQ: ADTX), an innovation platform dedicated to accelerating promising health innovations, and its majority-owned subsidiary, Pearsanta Inc., have signed a market development collaboration agreement with Evofem Biosciences (OTCQB: EVFM), a women’s health company. According to the announcement, the agreement involves Pearsanta’s blood-based diagnostic test for endometriosis, which affects an estimated 190 million women globally. The […]
InvestorNewsBreaks – Aditxt Inc. (NASDAQ: ADTX) Subsidiary Seeks Grant Funding to Advance Early Detection, Management of Prostate Cancer
Aditxt (NASDAQ: ADTX), a company dedicated to discovering, developing and deploying promising health innovations, today announced that its subsidiary, Pearsanta, Inc., has submitted a grant application to the Prostate Cancer Research Program (“PCRP”) under the Department of Defense (“DoD”) Implementation Science Award funding mechanism. Pearsanta is seeking $2 million in non-dilutive funding to advance the […]
Aditxt to Present at the H.C. Wainwright 26th Annual Global Investment Conference September 9th-11th, 2024
Aditxt Announces Third Amendment to Arrangement Agreement with Appili Therapeutics
Evofem Biosciences Addresses the Impact of GLP-1 Medications on Oral Contraceptive Absorption and Introduces Phexxi as a Non-Oral Solution
/PRNewswire/ -- As the popularity of GLP-1 receptor agonists continues to surge in the treatment of obesity and type 2 diabetes, Evofem Biosciences, Inc....
ADTX Stock Earnings: Aditxt Reported Results for Q2 2024
Aditxt just reported results for the second quarter of 2024.
ADTX Stock Earnings: Aditxt Reported Results for Q2 2024
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Aditxt (NASDAQ:ADTX) just reported results for the second quarter of 2024.Aditx...
BioMedNewsBreaks — Evofem Biosciences Inc. (EVFM) Releases Second-Quarter 2024 Financial Results, Company Update
Evofem Biosciences (OTCQB: EVFM) is reporting on its financial results and corporate update for Q2 2024; the report also included a report on the first half of 2024. Aditxt (NASDAQ: ADTX), a company dedicated to discovering, developing and deploying promising health innovations, entered into a merger agreement with Evofem last year; the agreement was amended and […]